genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Gene Therapy
Laying the Foundation for CF Therapy: An Interview with Michael Boyle
Coronavirus
Beyond the Spike: The COVAXX Approach to a COVID-19 Vaccine
Bioprocessing
Cytiva Plans $500M Expansion, 1,000 New Hires Worldwide
Coronavirus
A ‘Human’ Touch vs. COVID-19
Gene Therapy
AGTC Sets Sights on Late-Stage Retinitis Pigmentosa Gene Therapy Trial
News
Antibacterials
Dangerous E. coli Strain Reveals Potential New Drug Target
Antibacterials
Genome of Fleming’s Original Penicillium Strain Could Point to New Routes…
OMICs
Scientists Build Most Extensive Cell Atlas of the Human Heart
Artificial Intelligence
How AI Scratches More Than Just the Surface in Neurodegeneration
Cancer
Blueberry Compound May Provide New Inflammatory Bowel Disease Therapy
Insights
All
Trends for 2020
Bioprocessing
Novel Tech Approaches for Analyzing Aggregation
Bioprocessing
Data Management in the DNA of New Gene Therapy Plant
Bioprocessing
Personalized Medicine Manufacturing Needs “Debugging Tools”
A-Lists
Top 50 NIH-Funded Institutions of 2020
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Antibacterials
Dangerous E. coli Strain Reveals Potential New Drug Target
Antibacterials
Genome of Fleming’s Original Penicillium Strain Could Point to New Routes…
OMICs
Scientists Build Most Extensive Cell Atlas of the Human Heart
Cancer
Blueberry Compound May Provide New Inflammatory Bowel Disease Therapy
Magazine
All
Supplement
September 2020 Vol. 40 No. 9
Cold Cases Heat Up with New Forensic DNA Methods
September 2020 Vol. 40 No. 9
CRISPR Value Chains Support New Therapeutic Strategies
September 2020 Vol. 40 No. 9
Nonviral CRISPR Delivery Vehicles Lay the Smart Siege
Point of View
Multimodal Screening—The Future of Drug Discovery and Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Biodefense/Bioterrorism
Biodefense/Bioterrorism
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Biodefense/Bioterrorism
Intranasal Anthrax Vaccine Candidate “Off to the Races”
Biodefense/Bioterrorism
Removing Anthrax Bacterial Armor May Lead to New Therapies
Biodefense/Bioterrorism
Spero Wins Up to $54M Toward Development of Lead Antibiotic SPR994 for UTI
Biodefense/Bioterrorism
Bavarian Nordic Wins Up-to-$36M DoD Contract toward Equine Encephalitis Vaccine
Biodefense/Bioterrorism
GMO Safety Factor Prevents Fruitful Interbreeding in the Wild
Biodefense/Bioterrorism
Bavarian Nordic Wins Up-to-$539M BARDA Contract for Smallpox Vaccine
Biodefense/Bioterrorism
Emergent Wins $63M BARDA Contract for Cyanide Antidote Spray Device
Biodefense/Bioterrorism
U.S. DOD to Start New Trial with Pluristem’s PLX-R18 Cell Therapy...
Biodefense/Bioterrorism
Malware Hidden in Synthetic DNA Could Infect Sequencing Systems
Biodefense/Bioterrorism
MerLion, Dstl Score DTRA Grant to Support Biothreat Antibiotic Development
Biodefense/Bioterrorism
Emergent Confirms $100M BARDA Contract for Anthrax Vaccine Stockpiling
Biodefense/Bioterrorism
Pluristem, NYBC Win $900K to Test PLX-R18 Cells Alongside Cord Blood...
Biodefense/Bioterrorism
DNA Electronics Wins Up-to-$51.9M BARDA Contract
Biodefense/Bioterrorism
Profusa Wins $7.5M DARPA Biosensor Grant
Biodefense/Bioterrorism
Allergan and AstraZeneca Commit to Antibiotic Development Deal
Load more
Scroll Up
Please share your location to continue
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Drug resistant E. coli could be rapidly detected using newly developed technique. [NIH]](https://www.genengnews.com/wp-content/uploads/2018/08/24661308922_3eb66388f6_o8020087571-218x150.jpg "Dangerous E. coli Strain Reveals Potential New Drug Target")
